首页> 外文期刊>World Journal of Gastroenterology >Therapeutic effects of Caspase-1 inhibitors on acute lung injury in experimental severe acute pancreatitis
【24h】

Therapeutic effects of Caspase-1 inhibitors on acute lung injury in experimental severe acute pancreatitis

机译:Caspase-1抑制剂对实验性重症急性胰腺炎急性肺​​损伤的治疗作用

获取原文
获取原文并翻译 | 示例
       

摘要

AIM: To assess the therapeutic effect of Caspase-1 inhibitors (ICE-I) on acute lung injury (ALI) in experimental severe acute pancreatitis (SAP). METHODS: Forty-two SD rats were randomly divided into 3 groups: healthy controls (HC, n = 6); SAP-S group (n = 18); SAP-ICE-I group (n = 18). SAP was induced by retrograde infusion of 5% sodium taurocholate into the bile-pancreatic duct. HC rats underwent the same surgical procedures and duct cannulation without sodium taurocholate infusion. In SAP-S group, rats received the first intraperitoneal injection of isotonic saline 2 h after induction of acute pancreatitis and a repeated injection after 12 h. In SAP-ICE-I group, the rats were firstly given ICE inhibitors intraperitoneally 2 h after induction of pancreatitis. As in SAP-S group, the injection was repeated at 12 h. Serum IL-1β was measured by ELISA. Intrapulmonary expression of Caspase-1, IL-1β and IL-18 mRNA were detected by semi-quantitative RT-PCR. The wet/dry weight ratios and histopathological changes of the lungs were also evaluated. RESULTS: Serum IL-1β levels in SAP-S group were 276.77 ± 44.92 pg/mL at 6 h, 308.99 ± 34.95 pg/mL at 12 h, and 311.60 ± 46.51 pg/mL at 18 h, which were increased significantly (P < 0.01, vs HC). In SAP-ICE-I group, those values were decreased significantly (P < 0.01, vs SAP-S). Intrapulmonary expression of Caspase-1, IL-1β and IL-18 mRNA were observed in the HC group, while they were increased significantly in the SAP-S group (P < 0.01, vs HC). The expression of IL-1β and IL-18 mRNA were decreased significantly in the SAP-ICE-I group (P < 0.01, vs SAP-S), whereas Caspase-1 mRNA expression had no significant difference (P > 0.05). The wet/dry weight ratios of the lungs in the SAP-S group were increased significantly (P < 0.05 at 6 h, P < 0.01 at 12 h and 18 h, vs HC) and they were decreased significantly in the SAP-ICE-I group (P < 0.05, vs SAP-S). Caspase-1 inhibitors ameliorated the severity of ALI in SAP. CONCLUSION: Caspase-1 activation, and overproduction of IL-1β and IL-18 play an important role in the course of ALI, and Caspase-1 inhibition is effective for the treatment of ALI in experimental SAP.
机译:目的:评估Caspase-1抑制剂(ICE-1)对实验性严重急性胰腺炎(SAP)中急性肺损伤(ALI)的治疗作用。方法:42只SD大鼠随机分为3组:健康对照组(HC,n = 6);健康对照组(n = 6)。 SAP-S组(n = 18); SAP-ICE-I组(n = 18)。通过向胆胰管逆行输注5%牛磺胆酸钠来诱导SAP。 HC大鼠接受相同的手术程序和导管插管,但无牛磺胆酸钠灌注。在SAP-S组中,大鼠在诱发急性胰腺炎后2小时接受腹腔注射等渗盐水,并在12小时后重复注射。在SAP-ICE-1组中,诱导胰腺炎后2小时首先腹膜内给予ICE抑制剂。与SAP-S组一样,在12 h重复注射。通过ELISA测量血清IL-1β。半定量RT-PCR检测Caspase-1,IL-1β和IL-18 mRNA的肺内表达。还评估了湿/干重量比和肺的组织病理学变化。结果:SAP-S组血清IL-1β水平在6 h时为276.77±44.92 pg / mL,在12 h时为308.99±34.95 pg / mL,在18 h时为311.60±46.51 pg / mL,均显着升高(P <0.01,而HC)。在SAP-ICE-1组中,这些值显着降低(与SAP-S相比,P <0.01)。在HC组中观察到Caspase-1,IL-1β和IL-18 mRNA的肺内表达,而在SAP-S组中则显着增加(P <0.01,vs HC)。在SAP-ICE-1组中,IL-1β和IL-18 mRNA的表达显着降低(P <0.01,与SAP-S相比),而Caspase-1 mRNA的表达无显着差异(P> 0.05)。 SAP-S组的肺湿重/干重比显着增加(与HC相比,在6 h时P <0.05,在12 h和18 h时P <0.01),而在SAP-ICE-我分组(P <0.05,相对于SAP-S)。 Caspase-1抑制剂改善了SAP中ALI的严重程度。结论:Caspase-1的活化,IL-1β和IL-18的过量产生在ALI的发病过程中起重要作用,而Caspase-1的抑制作用对实验性SAP有效。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号